- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in uveal melanoma treatment
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume 37, Issue 6, Pages 1350-1372
Publisher
Wiley
Online
2017-07-31
DOI
10.1002/med.21460
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Long Non-Coding RNA RHPN1-AS1 Promotes Uveal Melanoma Progression
- (2017) Linna Lu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CANT1 lncRNA Triggers Efficient Therapeutic Efficacy by Correcting Aberrant lncing Cascade in Malignant Uveal Melanoma
- (2017) Yue Xing et al. MOLECULAR THERAPY
- The chemical evolution of oligonucleotide therapies of clinical utility
- (2017) Anastasia Khvorova et al. NATURE BIOTECHNOLOGY
- Melanoma Mutagenesis and Aberrant Cell Signaling
- (2017) Danielle M. Bello et al. Cancer Control
- Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands
- (2016) M. K. van der Kooij et al. ACTA ONCOLOGICA
- Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study
- (2016) F Mouriaux et al. BRITISH JOURNAL OF CANCER
- Uveal melanoma: From diagnosis to treatment and the science in between
- (2016) Chandrani Chattopadhyay et al. CANCER
- Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review
- (2016) Amanda YL Goh et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma
- (2016) V. Verma et al. CLINICAL ONCOLOGY
- Uveal melanoma: relatively rare but deadly cancer
- (2016) S Kaliki et al. EYE
- PAUPARlncRNA suppresses tumourigenesis by H3K4 demethylation in uveal melanoma
- (2016) Xia Ding et al. FEBS LETTERS
- The use of pembrolizumab for the treatment of metastatic uveal melanoma
- (2016) Lisa A. Kottschade et al. MELANOMA RESEARCH
- Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma
- (2016) Amanda R Moore et al. NATURE GENETICS
- The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma
- (2016) Nabil Amirouchene-Angelozzi et al. Oncotarget
- Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma
- (2016) Guillaume Carita et al. Oncotarget
- Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma
- (2016) Wei Dai et al. Scientific Reports
- Tumor Characteristics, Genetics, Management, and the Risk of Metastasis in Uveal Melanoma
- (2016) Erin E. Nichols et al. Seminars in Ophthalmology
- Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations
- (2016) Marta M. Stei et al. Biomed Research International
- Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma
- (2016) Ioannis Karydis et al. OncoImmunology
- Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases
- (2015) Marybeth S. Hughes et al. ANNALS OF SURGICAL ONCOLOGY
- Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticles
- (2015) Christian Posch et al. BIOMEDICAL MICRODEVICES
- Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT)
- (2015) Richard D. Carvajal et al. BMC CANCER
- IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma
- (2015) Isabella Venza et al. BMC Medical Genomics
- Upcoming translational challenges for uveal melanoma
- (2015) Amirouchene-Angelozzi Nabil et al. BRITISH JOURNAL OF CANCER
- miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications
- (2015) Marco Ragusa et al. CANCER BIOLOGY & THERAPY
- Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies
- (2015) Mark C. Burgmans et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Synthetic Nucleic Acid Delivery Systems: Present and Perspectives
- (2015) Bogdan Draghici et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mutant GNAQ promotes cell viability and migration of uveal melanoma cells through the activation of Notch signaling
- (2015) HONGLEI LIU et al. ONCOLOGY REPORTS
- Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
- (2015) Lisa Zimmer et al. PLoS One
- Ganetespib: research and clinical development
- (2015) Shanu Modi et al. OncoTargets and Therapy
- Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4
- (2015) Peter Johansson et al. Oncotarget
- siRNA Versus miRNA as Therapeutics for Gene Silencing
- (2015) Jenny K W Lam et al. Molecular Therapy-Nucleic Acids
- Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib
- (2014) Anna Niederkorn et al. ACTA OPHTHALMOLOGICA
- Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients
- (2014) Kalijn F. Bol et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial
- (2014) S. Leyvraz et al. ANNALS OF ONCOLOGY
- Effects of inhibition of hedgehog signaling on cell growth and migration of uveal melanoma cells
- (2014) Fei Duan et al. CANCER BIOLOGY & THERAPY
- Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
- (2014) Fa-Xing Yu et al. CANCER CELL
- Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
- (2014) Xiaodong Feng et al. CANCER CELL
- Recent developments in prognostic and predictive testing in uveal melanoma
- (2014) Matthew G. Field et al. CURRENT OPINION IN OPHTHALMOLOGY
- Class I-specific histone deacetylase inhibitor MS-275 overrides TRAIL-resistance in melanoma cells by downregulating c-FLIP
- (2014) Isabella Venza et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma
- (2014) Richard D. Carvajal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- GNAQ and GNA11 mutations in uveal melanoma
- (2014) Alexander N. Shoushtari et al. MELANOMA RESEARCH
- The Phosphoinositide 3-Kinase Selective Inhibitor BYL719 Enhances the Effect of the Protein Kinase C Inhibitor AEB071 in GNAQ/GNA11-Mutant Uveal Melanoma Cells
- (2014) E. Musi et al. MOLECULAR CANCER THERAPEUTICS
- Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target
- (2014) Nabil Amirouchene-Angelozzi et al. Molecular Oncology
- Expression of focal adhesion kinase in uveal melanoma and the effects of Hsp90 inhibition by 17-AAG
- (2014) Dana Faingold et al. PATHOLOGY RESEARCH AND PRACTICE
- Discovery of Novel AKT Inhibitors with Enhanced Anti-Tumor Effects in Combination with the MEK Inhibitor
- (2014) Melissa Dumble et al. PLoS One
- Genetic determinants of uveal melanoma
- (2014) Jasbir Kaur et al. TUMOR BIOLOGY
- Isolated hepatic perfusion for patients with liver metastases
- (2014) Srinevas K. Reddy et al. Therapeutic Advances in Medical Oncology
- Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
- (2014) Mihir Raval et al. Frontiers in Oncology
- Acid-Degradable Polymer-Caged Lipoplex (PCL) Platform for siRNA Delivery: Facile Cellular Triggered Release of siRNA
- (2013) Bong Jin Hong et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Inhibition of Mutant GNAQ Signaling in Uveal Melanoma Induces AMPK-Dependent Autophagic Cell Death
- (2013) G. Ambrosini et al. MOLECULAR CANCER THERAPEUTICS
- Crizotinib, a c-Met Inhibitor, Prevents Metastasis in a Metastatic Uveal Melanoma Model
- (2013) O. Surriga et al. MOLECULAR CANCER THERAPEUTICS
- Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations
- (2013) X Chen et al. ONCOGENE
- SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
- (2013) S. J. Furney et al. Cancer Discovery
- Tumor-Homing Poly-siRNA/Glycol Chitosan Self-Cross-Linked Nanoparticles for Systemic siRNA Delivery in Cancer Treatment
- (2012) So Jin Lee et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Recombinant oncolytic adenovirus H101 combined with siBCL2: cytotoxic effect on uveal melanoma cell lines
- (2012) Xiaolin Huang et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Metastatic Uveal Melanoma
- (2012) Scott E. Woodman CANCER JOURNAL
- Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11-Dependent Manner
- (2012) J. S. Khalili et al. CLINICAL CANCER RESEARCH
- Inflammation in uveal melanoma
- (2012) I H G Bronkhorst et al. EYE
- Molecular pathology of uveal melanoma
- (2012) S E Coupland et al. EYE
- Charged Particle Radiation Therapy for Uveal Melanoma: A Systematic Review and Meta-Analysis
- (2012) Zhen Wang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Single siRNA Nanocapsules for Enhanced RNAi Delivery
- (2012) Ming Yan et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Reductively Responsive siRNA-Conjugated Hydrogel Nanoparticles for Gene Silencing
- (2012) Stuart S. Dunn et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The genetics of uveal melanoma: an emerging framework for targeted therapy
- (2012) J. William Harbour Pigment Cell & Melanoma Research
- Class II-specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL-8 expression in human melanoma cells
- (2012) I. Venza et al. Pigment Cell & Melanoma Research
- The Protein Kinase C Inhibitor Enzastaurin Exhibits Antitumor Activity against Uveal Melanoma
- (2012) Xinqi Wu et al. PLoS One
- Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype
- (2012) Alan L. Ho et al. PLoS One
- Therapeutic Efficacy by Targeting Correction of Notch1-Induced Aberrants in Uveal Tumors
- (2012) Xiaolin Huang et al. PLoS One
- Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512
- (2012) Shailender Bhatia et al. PLoS One
- Therapeutic Implications of the Emerging Molecular Biology of Uveal Melanoma
- (2011) M. Patel et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma
- (2011) S. Landreville et al. CLINICAL CANCER RESEARCH
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
- (2011) Michelle C. Mendoza et al. TRENDS IN BIOCHEMICAL SCIENCES
- Human uveal melanoma cells inhibit the immunostimulatory function of dendritic cells
- (2010) Juan Ma et al. EXPERIMENTAL EYE RESEARCH
- Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
- (2010) J. W. Harbour et al. SCIENCE
- siRNA vs. shRNA: Similarities and differences
- (2009) Donald D. Rao et al. ADVANCED DRUG DELIVERY REVIEWS
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
- (2008) Catherine D. Van Raamsdonk et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started